Search research articles
Contact Us
Filters
Showing results (131-140 of 302) with videos related to
Page
of 31
Sort By:
Pharmacogenomics
|
August 27, 2014
Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction
Andrea Calcagno, Lorena Baietto, Nicole Pagani, et al.
Antiviral Therapy
|
February 16, 2017
Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia
Ilaria Motta, Tiziano Allice, Alessandra Romito, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 10, 2011
Interpretation of genotypic resistance to predict darunavir/ritonavir failure in antiretroviral experienced patients
Gaetana Sterrantino, Mauro Zaccarelli, Michele Trotta, et al.
International Journal of Antimicrobial Agents
|
January 18, 2016
Efavirenz pharmacogenetics in a cohort of Italian patients
Jessica Cusato, Cristina Tomasello, Marco Simiele, et al.
Diagnostics (Basel, Switzerland)
|
June 2, 2021
Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers
Giulia Caligaris, Mattia Trunfio, Valeria Ghisetti, et al.
Journal of Neurovirology
|
June 20, 2019
The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes
Mattia Trunfio, Claudia Manini, Alice Trentalange, et al.
British Journal of Clinical Pharmacology
|
June 12, 2012
Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices
Andrea Calcagno, Antonio D'Avolio, Marco Simiele, et al.
Optics Letters
|
January 28, 2004
Optimization of high-order harmonic generation by adaptive control of a sub-10-fs pulse wave front
Paolo Villoresi, Stefano Bonora, Michele Pascolini, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 22, 2017
UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma
Marco Simiele, Alessandra Ariaudo, Amedeo De Nicolò, et al.
British Journal of Clinical Pharmacology
|
January 19, 2017
Pharmacokinetics of first-line antitubercular drugs in plasma and PBMCs
Ilaria Motta, Andrea Calcagno, Lorena Baietto, et al.
Page
of 31
Search research articles
Search
Showing results (131-140 of 302) with videos related to
Sort By:
Page
of 31
Pharmacogenomics
|
August 27, 2014
Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction
Andrea Calcagno, Lorena Baietto, Nicole Pagani, et al.
Antiviral Therapy
|
February 16, 2017
Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia
Ilaria Motta, Tiziano Allice, Alessandra Romito, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 10, 2011
Interpretation of genotypic resistance to predict darunavir/ritonavir failure in antiretroviral experienced patients
Gaetana Sterrantino, Mauro Zaccarelli, Michele Trotta, et al.
International Journal of Antimicrobial Agents
|
January 18, 2016
Efavirenz pharmacogenetics in a cohort of Italian patients
Jessica Cusato, Cristina Tomasello, Marco Simiele, et al.
Diagnostics (Basel, Switzerland)
|
June 2, 2021
Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers
Giulia Caligaris, Mattia Trunfio, Valeria Ghisetti, et al.
Journal of Neurovirology
|
June 20, 2019
The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes
Mattia Trunfio, Claudia Manini, Alice Trentalange, et al.
British Journal of Clinical Pharmacology
|
June 12, 2012
Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices
Andrea Calcagno, Antonio D'Avolio, Marco Simiele, et al.
Optics Letters
|
January 28, 2004
Optimization of high-order harmonic generation by adaptive control of a sub-10-fs pulse wave front
Paolo Villoresi, Stefano Bonora, Michele Pascolini, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 22, 2017
UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma
Marco Simiele, Alessandra Ariaudo, Amedeo De Nicolò, et al.
British Journal of Clinical Pharmacology
|
January 19, 2017
Pharmacokinetics of first-line antitubercular drugs in plasma and PBMCs
Ilaria Motta, Andrea Calcagno, Lorena Baietto, et al.
Page
of 31